Controversial Cancer Grant Could Be Reconsidered (Wayne Roberts, MPAff '77) | LBJ School of Public Affairs | The University of Texas at Austin
Austin American Statesman
Go to Article

An $11 million grant at the center of the controversy surrounding the state’s cancer agency would likely be reconsidered for full funding if the Dallas startup, Peloton Therapeutics, receives a favorable review and is not implicated in the criminal investigation, an agency official said Tuesday.

Wayne Roberts, interim executive director who inherited the problems at the Cancer Prevention and Research Institute of Texas, made his comments at a hearing before the House Committee on Public Health and in an interview afterwards.